SCHEMBL4888487

SCHEMBL4888487

O=C(O)C1=CN(Cl)N(Cc2ccccc2)C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.41
PARP1 P09874 1/20 0.40
GAA P10253 1/20 0.40
LMNA P02545 2/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ADRA1D P25100 1/20 0.38
FUCA1 P04066 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
HTR2B P41595 1/20 0.38
MAPK14 Q16539 1/20 0.38
POLB P06746 1/20 0.37
CYP2D6 P10635 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 1/20 0.37
SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15520048 0.69 SIGMAR1 (0.44) GAALMNATSHRSMN1; SMN2CYP2C9
SCHEMBL22092518 0.69 NOTUM (0.40) NOTUMLMNASMN1; SMN2FUCA1CYP2C9
SCHEMBL28039452 0.68 SIGMAR1 (0.47) LMNATSHRSMN1; SMN2FUCA1KMT2A
SCHEMBL5777725 0.66 SIGMAR1 (0.54) LMNATSHRSMN1; SMN2FUCA1CYP2C9
SCHEMBL11322736 0.66 PARP1 (0.45) PARP1CYP2C9CYP2C19POLBCYP2D6
SCHEMBL11136071 0.66 SLC6A1 (0.57) LMNACYP2C9CYP2C19CYP2D6KMT2A
SCHEMBL2805436 0.66 CCR2 (0.39) NOTUMGAALMNATSHRSMN1; SMN2
SCHEMBL1263511 0.66 HCRTR1 (0.48) LMNATSHRSMN1; SMN2CYP2C9CYP2C19
SCHEMBL1397071 0.65 ADRA1D (0.39) PARP1GAALMNATSHRSMN1; SMN2
SCHEMBL17196485 0.65 SIGMAR1 (0.56) LMNAFUCA1POLBKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES ICAGEN, INC. (US) 2008-03-13 US disclosed
US-7223782-B2 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2007-05-29 US disclosed
US-20050049237-A1 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2005-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES SCN3A, TRPV3, HCN3 NOTUM 3410/4885PARP1 3600/4885GAA 4722/4885
US-20050049237-A1 Pyrazole-amides and -sulfonamides SCN3A, TRPV3, HCN3 NOTUM 3410/4885PARP1 3600/4885GAA 4722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.